TESSERA THERAPEUTICS
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
TESSERA THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Life Science Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tesseratherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
531.76 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Tag Manager Google Analytics LetsEncrypt SSL By Default Global Site Tag Organization Schema
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Beyond Air
Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.
ArcherDX
ArcherDX is a biotechnology firm specializing in cancer research.
Ascidian Therapeutics
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
Black Diamond Therapeutics
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Element Biosciences
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
Longevity Vision Fund
Longevity Vision Fund investment in Series C - Tessera Therapeutics
SALT Fund
SALT Fund investment in Series C - Tessera Therapeutics
Hanwha Impact Partners
Hanwha Impact Partners investment in Series C - Tessera Therapeutics
March Capital
March Capital investment in Series C - Tessera Therapeutics
Alaska Permanent Fund
Alaska Permanent Fund investment in Series C - Tessera Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Tessera Therapeutics
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series C - Tessera Therapeutics
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Tessera Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series C - Tessera Therapeutics
Artis Ventures (AV)
Artis Ventures (AV) investment in Series C - Tessera Therapeutics
Official Site Inspections
http://www.tesseratherapeutics.com Semrush global rank: 1.78 M Semrush visits lastest month: 12.63 K
- Host name: 413450.cloudwaysapps.com
- IP address: 167.172.146.87
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047
More informations about "Tessera Therapeutics"
Tessera Therapeutics - Crunchbase Company Profile
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing …See details»
Focus Areas - Tessera Therapeutics
At Tessera, we are advancing our Gene Writing™ technology and proprietary LNP delivery system to alter the human genome and effect precise, durable therapeutic change to cure …See details»
Tessera Therapeutics - LinkedIn
A special thank you to our partner organization, Boston Cares, for connecting us with organizations making a positive impact. Together, we can create a better future. Together, we can create a ...See details»
Biology - Tessera Therapeutics
In recent years, we’ve made extraordinary leaps in genetic medicine, with two pillar technologies emerging: gene therapy and gene editing. While these methods are offering potential cures for select diseases, they are not without …See details»
Tessera Therapeutics Company Profile 2024: Valuation, Funding ...
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20240252682-A1: Hbb-modulating compositions and methods: Pending: 08-Sep-2021See details»
Tessera Therapeutics, Inc. Company Profile | Cambridge, MA ...
Find company research, competitor information, contact details & financial data for Tessera Therapeutics, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Tessera Therapeutics - Overview, News & Similar companies
Feb 19, 2024 Tessera Therapeutics contact info: Phone number: (857) 356-4700 Website: www.tesseratherapeutics.com What does Tessera Therapeutics do? Tessera Therapeutics is …See details»
Tessera Therapeutics - Company Profile - Tracxn
Nov 17, 2024 Tessera Therapeutics - Provider of new genome engineering technology for treating multiple diseases. Raised a total funding of $532M over 2 rounds from 19 investors. Founded by Geoffrey Von Maltzahn, Jacob Rubens …See details»
Tessera Therapeutics - Overview, News & Similar companies
View Tessera Therapeutics (www.tesseratx.com) location in United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Tessera Therapeutics Adds New Executives to its ... - Business Wire
Dec 8, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, a biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™ …See details»
Tessera Therapeutics - Flagship Pioneering
Latest News from Tessera Therapeutics. Michael Severino, M.D., Joins Flagship Pioneering-Founded Tessera Therapeutics as Chief Executive Officer 06.02.2022; Tessera Therapeutics …See details»
Tessera Therapeutics Expands Leadership and Board
Aug 24, 2022 During her decade with Voisin, she contributed to the organization’s global growth from three employees to more than 70. Ms. Eggimann currently serves on the board of Codiak …See details»
News - Tessera Therapeutics
11.05.2024 | Press Release Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of …See details»
Tessera Therapeutics Announces Over $300M Series C
Apr 19, 2022 For more information on Tessera Therapeutics, including how GENE WRITING technology works, partnership opportunities, and job openings, please visit …See details»
Careers - Tessera Therapeutics
Our dedicated team is pioneering Gene Writing™ - a new genome engineering technology that writes in the code of life. We are looking for creative thinkers who can help fuel this ambitious …See details»
Leading Gene Writing Company Tessera Therapeutics Announces …
Jul 14, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, a biotechnology company pioneering a new approach in genetic medicine known as Gene Writing, announced …See details»
Tessera Therapeutics Announces Over $300M… | Flagship Pioneering
Apr 19, 2022 For more information about Tessera, please visit www.tesseratherapeutics.com. About Flagship Pioneering. Flagship Pioneering conceives, creates, resources, and develops …See details»
Tessera Therapeutics Highlights Advances Across In Vivo Programs …
23 hours ago For more information about Tessera, please visit www.tesseratherapeutics.com. Contact. Kristin Politi, PhD LifeSci Communications, LLC [email protected]See details»
Tessera Therapeutics Highlights Advances Across In Vivo Programs …
1 day ago In vivo proof-of-concept achieved in humanized mice and non-human primates (NHPs) using Gene Writers encapsulated in proprietary lipid nanoparticles (LNPs) targeting …See details»
Delivery - Tessera Therapeutics
LNPs can safely and effectively deliver nucleic acids to cells without eliciting a robust immune response as is common with viral delivery vectors.See details»